SHR-3045 Injection

DRUG3 trials

Sponsors

Guangdong Hengrui Pharmaceutical Co., Ltd

Conditions

Moderate to Severe Active Rheumatoid ArthritisRheumatoid ArthritisRheumatoid Arthritis (RA)

Phase 1

A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects

CompletedNCT06883695

Guangdong Hengrui Pharmaceutical Co., LtdRheumatoid Arthritis

Start: 2025-04-08End: 2025-10-10Updated: 2026-06-05

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

CompletedNCT07200596

Guangdong Hengrui Pharmaceutical Co., LtdRheumatoid Arthritis (RA)

Start: 2025-10-08End: 2026-03-31Updated: 2026-06-11

Phase 2

A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

Active, not recruitingNCT07233655

Guangdong Hengrui Pharmaceutical Co., LtdModerate to Severe Active Rheumatoid Arthritis

Start: 2026-01-19End: 2026-07-01Updated: 2026-05-01